Biliary Dyspepsia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia (NCT07016269) | Myungmoon Pharma. Co. Ltd. | 2025-08-29 |
Track Biliary Dyspepsia automatically
Every clearance here is in the API, with alerts when new ones post.